期刊文献+

大剂量地塞米松治疗过敏性紫癜致严重精神障碍1例

A Case of High-dose Dexamethasone Caused Severe Psychiatric Disorders for Treatment of Henoch-Schonlein Purpura
下载PDF
导出
摘要 1例17岁女性患者因过敏性紫癜入院,初始精神无异常,地塞米松20 mg/d静脉输注5 d后逐渐出现情绪低落,莫名哭泣、睡眠障碍等症状,且逐渐加重。地塞米松使用2周后,患者出现躁狂、抑郁混合型精神障碍,遂予利妥昔单抗联合治疗,迅速停用地塞米松续贯泼尼松片口服。患者过敏性紫癜控制后出院转至精神专科医院,经抗精神病药物治疗,患者精神障碍在20 d内逐渐恢复至完全正常。本例精神障碍很可能与地塞米松有关,提醒临床应重视早期识别糖皮质激素导致的精神障碍,掌握正确处置该类不良反应的方法。 A 17-year-old female was treated with high-dose dexamethasone for henoch-schonlein purpura.At the beginning,there was no psychiatric disorders,however,after receiving dexamethasone(20 mg/d)intravenous infusion for 5 days,the patient gradually appeard depression,inexplicable crying,sleep disturbance and other symptoms,which gradually worsened.Two weeks later,the patient developed mixed psychiatric disorders with manic and depressive.In view of this situation,dexamethasone was quickly stopped,and then prednisone tablets were taken orally.The henoch-schonlein purpura of the patient was controlled and then was transferred to a psychiatric hospital,where the patient's psychiatric disorder gradually returned to normal within 20 days after treatment with antipsychotic drugs.In this case,the psychiatric disorders was probably related to dexamethasone.It was suggested that we should pay attention to early identification of mental disorders caused by glucocorticoids and master the correct disposal of such adverse reactions.
作者 熊亚群 周仕海 肖幸华 罗平 XIONG Yaqun;ZHOU Shihai;XIAO Xinghua;LUO Ping(Xiangya Hospital of Central South University,Changsha Hunan 410008,China;Xiangya Changde Hospital,Changde Hunan 415000,China;Guiyang Hospital of Guihang,Guiyang Guizhou 550001,China)
出处 《药品评价》 CAS 2022年第1期31-34,共4页 Drug Evaluation
关键词 地塞米松 精神障碍 药物相关性副作用和不良反应 过敏性紫癜 Dexamethasone Psychiatric disorders Drug-related side effects and adverse reactions Henoch-schonlein purpura
  • 相关文献

参考文献5

二级参考文献133

  • 1王秉慧,周丽群,左亚华.儿童腹型过敏性紫癜与幽门螺杆菌感染的关系探讨[J].中国当代儿科杂志,2007,9(4):367-369. 被引量:31
  • 2WHO. Severe acute respiratory syndrome(SARS)[S].Wkly Epideiol Rec, 2003, 78:81-83.
  • 3Schacke H, Docke WD, Asadullah K. Mechanisms involved in the effects of glucocorticoids[J]. Pharmacol Ther, 2002,96(1):23.
  • 4Boss JH, Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals[J]. Vet Pathol, 2003,40(4):345.
  • 5Mirzai R, Chang C, Greenspan A, et al. The pathogenesis of osteonecrosis and the relationships to corticosteroids [J].J Asthma,1999,36(1):77.
  • 6Gebhard KL, Maibach HI. Relationship between systemic corticosteroids and osteonecrosis[J]. Am J Clin Dermatol, 2001,2(6):377.
  • 7Suwalska A, Lojko D, Rybakowski J. Psychiatric complications of glucocorticoid treatment [J]Psychiatr Pol, 2002,36(2):271.
  • 8Belanoff JK, Gross K, Yager A, et al. Corticosteroids and cognition [J].J Psychiatr Res, 2001,35(3):127.
  • 9北京防治非典型肺炎联合工作小组.传染性非典型肺炎推荐治疗方案 联合小组发[2003]4号[Z].,2003-5-5..
  • 10刘燕玲.骨坏死谁之过[N].健康报,2003-10-16(3).

共引文献371

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部